Please login to the form below

Not currently logged in
Email:
Password:

Hollingsworth leaves cancer charity for ABPI

Andrew Hollingsworth appointed policy manager at pharma industry body

Andrew Hollingsworth is to leave the third sector to join industry, moving from Cancer Research UK to the Association of the British Pharmaceutical Industry (ABPI).

Hollingsworth will join the UK pharma trade body on November 25 as policy manager. He leaves his role as public affairs manager at Cancer Research UK.

He will use his experience in the third sector in his new role, which will see him lead the ABPI's work to engage with patient groups. This includes the Patient Organisation Forum, which aims to identify mutual interest and improve collaboration between industry and patient organisations.

Hollingsworth also has industry experience spending more than five years at Novartis a senior manager, public affairs. This followed a period in politics as parliamentary assistant in the European Parliament.

Commenting on his new role, Hollingsworth said: “I am keen to develop the ABPI's engagement with patient organisations in an open, transparent and constructive dialogue."

13th November 2013

From: Research, Sales, Marketing, Regulatory, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
ben.quarless@publicishealth.com

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics